The specific reduction of CRP, along with simultaneous removal of bacterial cells and toxins, therefore becomes a major point of strength of this medical device, because it directly reduces all the processes of inflammatory activation and progression that occur in sepsis when antibiotics and supportive therapies are failing. The gene discussed is CRP; the disease is Sepsis.